Prospective trial registration for clinical research: What is it, what is it good for, and why do i care?

Regional Anesthesia and Pain Medicine

Volumn 36, Issue 6, 2011, Pages 619-624

  Fredrickson, Michael J ^a   Ilfeld, Brian M ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; ANESTHESIOLOGY; ARTICLE; AWARENESS; CLINICAL RESEARCH; DATA ANALYSIS; DOCUMENTATION; INTERNET; MEDICAL RESEARCH; PATIENT CARE; PRIORITY JOURNAL; REGISTER; REGISTRATION; WORLD HEALTH ORGANIZATION;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 80055093736     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0b013e318230fbc4     Document Type: Article

References (26)

1. Dickersin K. Report from the panel on the Case for Registers of Clinical Trials at the Eighth Annual Meeting of the Society for Clinical Trials. Control Clin Trials. 1988;9:76-81. (Pubitemid 18080726)
2. Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol. 1986;4:1529-1541. (Pubitemid 17183579)
3. Scherer RW, Dickersin K, Langenberg P. Full publication of results initially presented in abstracts. A meta-analysis. JAMA. 1994;272:158-162.
4. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med. 2008;5:e191.
5. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med. 2008;5:e217; discussion e217.
6. Bennett CL, Silver SM, Djulbegovic B, et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008;299:914-924. (Pubitemid 351397066)
7. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356:2457-2471. (Pubitemid 46919772)
8. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
9. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med. 2009;6:e1000144.
10. Decullier E, Lheritier V, Chapuis F. Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ. 2005;331:19.
11. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA. 1992;267:374-378.
12. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ. 1997;315: 640-645. (Pubitemid 27387174)
13. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726-732.
14. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457-2465. (Pubitemid 38669189)
15. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev. 1997;9:15-21.
16. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000;284:1247-1255.
17. Horton R. Vioxx, The implosion of Merck, and aftershocks at the FDA. Lancet. 2004;364:1995-1996. (Pubitemid 39593061)
18. Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364:2021-2029. (Pubitemid 39593078)
19. Wessely S, Kerwin R. Suicide risk and the SSRIs. JAMA. 2004;292:379-381. (Pubitemid 38944264)
20. Ghersi D, Pang T. En route to international clinical trial transparency. Lancet. 2008;372:1531-1532.
21. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302:977-984.
22. Zarin DA, Tse T, Ide NC. Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;353:2779-2787. (Pubitemid 43016817)
23. Tse T, Williams RJ, Zarin DA. Update on registration of clinical trials in Clinical Trials.gov. Chest. 2009;136:304-305.
24. Wood AJ. Progress and deficiencies in the registration of clinical trials. N Engl J Med. 2009;360:824-830.
25. Sim I, Chan AW, Gulmezoglu AM, Evans T, Pang T. Clinical trial registration: transparency is the watchword. Lancet. 2006;367: 1631-1633. (Pubitemid 43728234)
26. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database - update and key issues. N Engl J Med. 2011;364:852-860.